Stay updated on Immuno-Therapy in Newly Diagnosed GBM Clinical Trial

Sign up to get notified when there's something new on the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:59:41.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a shift in the number of participants enrolled in the clinical trial for patients with MGMT-methylated glioblastoma receiving temozolomide plus radiation therapy with nivolumab or placebo. This change reflects an update in the study's enrollment data, potentially impacting the ongoing evaluation of treatment outcomes in the trial.
    Difference
    0.1%
    Check dated 2024-06-06T14:28:25.000Z thumbnail image
  7. Check
    16 days ago
    Change Detected
    Summary
    The value (Estimated) has recently changed to . This change likely indicates an update or revision in the estimated information related to the medical and healthcare-related publications and documentation on the webpage.
    Difference
    0.0%
    Check dated 2024-05-31T10:33:07.000Z thumbnail image
  8. Check
    17 days ago
    Change Detected
    Summary
    The value 'Active, not recruiting' has recently changed to 'Completed' on the webpage. This change indicates that the study related to Medical and healthcare publications and documentation has been completed successfully.
    Difference
    0.9%
    Check dated 2024-05-30T09:33:51.000Z thumbnail image
  9. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' providing examples such as general health condition or prior treatments. Additionally, it now includes a link for more information about clinical research and Bristol-Myers Squibb Clinical Trial participation.
    Difference
    7%
    Check dated 2024-05-22T21:02:10.000Z thumbnail image
  10. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:26:21.000Z thumbnail image

Stay in the know with updates to Immuno-Therapy in Newly Diagnosed GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page.